Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients.

JCEM Case Rep · 2024 · PMC10943497 · PMID 38495394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A double-blind, placebo-controlled study of teriparatide in 26 deceased donor renal transplant recipients showed a trend toward reducing bone loss after transplant ( 5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.